Real World Data Spring Event 2025

Announcing a brand new PHUSE Event, hosted by the Real World Evidence Working Group!

"The PHUSE Real World Data Spring Event will build upon the engagement in the Real World Evidence Projects, Community Forums and PHUSE CSS break-out sessions. It will bring together engaged speakers from the field ranging from data vendor and data registry representatives to pharmaceutical and biotech industry representatives who are sharing their knowledge and ideas around Real World Data utilisation in a fast-moving and challenging environment."

Berber Snoeijer, ClinLine – Real World Evidence Working Group Lead

The Real World Data Spring Event took place on 9–10 April

Presentation Information can be found here.

Date	Presentation	Author(s)
Day 1: 9 April Theme - Real World Data Utilisation: Use Cases	How AI Is Transforming Unstructured Healthcare Data into Actionable Insights	Aracelis Torres, Verana Health
	Leveraging Real World Data for Safety Assessments in the Drug Development Life Cycle	Harini Vadlamudi, GSK
	The Patient-Mediated Approach To Collecting Real World Data	Ashley Pitcher, IQVIA
	Leveraging RWD To Streamline Clinical Trial Recruitment and Pragmatic Study Execution	Joanna Guild & Abhishek Dabral, Flatiron Health
Day 2: 10 April Theme - Standardisation, Compliance, and Data Reliability in Real World Evidence	Verifying the Quality and Reliability of Data Through Cryptography	Ali Dootson, EQTY Life Sciences
	A New CDISC Standard for Reliable Real World Data (RWD)	Tasha Nagamine, Droice Labs & Anita Umesh, Genentech/Roche
	Towards Standardised and Regulated RWD-Based Treatment Comparisons	Tamas Soroncz-Szabo, Takeda

Sponsorship
Hosting the Real World Data Spring Event digitally means that no matter where you are in the world you can participate. It provides the industry with a broader opportunity to share knowledge on a global scale, connecting through the virtual event platform. The sponsor options offer a range of benefits with ample company exposure. See the prospectus for more details.

Real World Evidence Working Group Leads